0 items USD 0.00Search
- Did you mean
- rheumatoid arthrex
Your search for "Rheumatoid arthritis" gave back 708 results.
Septic arthritis is a disease caused by a bacterial infection or invasion in the joints leading to inflammation. Symptoms of septic arthritis include...
Catalog:
GIR
January 2023
Price: USD 3,480.00
Treatment of drugs for regulating rheumatic diseases The “Rheumatic Disorders Drug Industry Forecast” looks at past sales and reviews total world...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Abatacept (marketed as Orencia) is a drug used to treat autoimmune diseases like rheumatoid arthritis, by interfering with the immune activity of T...
Catalog:
LPI
February 2023
Price: USD 3,660.00
A TNF inhibitor is a pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF), which is part of the inflammatory...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global Remicade (Infliximab) Monoclonal Antibody market size is projected to grow from US$ 2494.5 million in 2022 to US$ 3703.9 million in 2029;...
Catalog:
LPI
June 2023
Price: USD 3,660.00
Tofacitinib, sold under the brand Xeljanz among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative...
Catalog:
GIR
January 2023
Price: USD 3,480.00
Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more...
Catalog:
GIR
April 2023
Price: USD 3,480.00
Arthritis Monoclonal Antibodies are a group of complex and effective biological agents used to treat arthritis and other immune-mediated inflammatory...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
The global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Celecoxib capsules (patent brand name: CELEBREX), is a new generation of non-steroidal anti-inflammatory and analgesic drugs, mainly through the...
Catalog:
LPI
January 2023
Price: USD 3,660.00
The global Remicade (Infliximab) Monoclonal Antibody market size is expected to reach $ 3781.3 million by 2029, rising at a market growth of 5.4%...
Catalog:
GIR
June 2023
Price: USD 4,480.00
The global Specialty Drug Distribution market size was valued at US$ 261790 million in 2023. With growing demand in downstream market, the Specialty...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Abatacept (marketed as Orencia) is a drug used to treat autoimmune diseases like rheumatoid arthritis, by interfering with the immune activity of T...
Catalog:
GIR
January 2023
Price: USD 3,480.00
The global Celecoxib market size was valued at US$ 1243.6 million in 2023. With growing demand in downstream market, the Celecoxib is forecast to a...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Enbrel is a biopharmaceutical that treats autoimmune diseases by interfering with tumor necrosis factor (TNF, a soluble inflammatory cytokine) by...
Catalog:
LPI
March 2023
Price: USD 3,660.00
